Connect with us

Wellness

Malnutrition crisis: Britain’s hidden modern diet epidemic

New research reveals a decline in diet and nutrition of Brits with over half admitting they have noticed a shift in the past decade

Published

on

Melissa Snover, founder and CEO of Nourished
Nourished, the UK’s leader in personalised nutrition solutions, has released alarming new data highlighting a surge in poor diet and malnutrition across the UK, with over half of Brits reporting a decline in their diet and nutrition in the past decade.

This growing crisis is particularly acute among younger generations and is compounded by increasing pressures to lose weight through unhealthy measures such as crash diets, weight loss supplements and injections.

According to the new study, young adults (18-24) are the hardest hit, with 69 per cent admitting to poor diet and nutrition, followed by 57 per cent of 25-34 and 56 per cent of 35 to 44-year-olds.

Regional disparities are stark, with Scotland (64 per cent) and the North East and West Midlands (63 per cent) experiencing significant diet shifts due to rising food costs.

Per city, those living in Portsmouth struggling the most with eight in 10 (82 per cent), followed by Glasgow at 72 per cent and Coventry, Liverpool, Norwich and Worcester all equally sitting at 71 per cent

In the new poll, almost half (45 per cent) of those surveyed admitted to rarely or never considering the nutritional value of the food they eat.

Over half (53 per cent) of Brits are instead prioritising convenience and cost over nutritional value with 27 per cent admitting speed and ease of preparation is a key factor driving the decision over the food they eat. Cost is also crucial, with 26 per cent listing this as their top reason for food choices.

Only Baby Boomers (65 and over) are likely to choose nutritional value regardless of cost, with 46 per cent admitting this is the key factor driving decisions over what they choose to eat.

Thirty-five to 44-year-olds are least likely to prioritise the nutritional value of their diet with just over a quarter (28 per cent) citing this as the main driver for food choices. This age group is also the most likely to opt for speed and ease of preparation over anything else, with over a third admitting this is their top priority when choosing what to eat (37 per cent).

Eighteen to 24-year-olds are feeling the pinch the most from rising food costs, with 40 per cent admitting price as the lead factor driving their food choices.

According to the British Dietetic Association (BDA), malnutrition in the UK is a pervasive issue affecting millions. The economic burden is colossal, with an estimated annual cost of £19.6bn in England alone. This figure reflects the increased healthcare needs, longer hospital stays, and the exacerbation of other health conditions linked to malnutrition. 

The weight of societal pressure

Adding to this concern is the fact that 40 per cent of people feel pressured to lose weight, with 21 per cent attempting crash diets, 13 per cent using weight loss supplements, and six per cent opting for weight loss injections.

Younger generations (58 per cent of 18-24-year-olds) and women (49 per cent) feel the pressure more acutely, with those living in Northern Ireland and Wales reporting the highest levels of weight loss pressure, at 54 per cent and 51 per cent, respectively.

Thirty-five to 44-year-olds are the most likely to try crash dieting to lose weight, with 31 per cent admitting to trying quick-fix diets as a way to lose weight.

Twenty-five to 34-year-olds are the most likely to use weight loss supplements with over a quarter (27 per cent) trying this method to shift the pounds.

Worryingly, one in five (20 per cent) of 18-24 year olds admitted to using weight loss injections. According to the data, men are more likely to opt for injections, with almost one in 10 (nine per cent) opting for this as their preferred way to lose weight.

Almost three in four Londoners (73 per cent) have tried quick-fix methods to lose weight, including 32 per cent trying crash diets, 24 per cent weight loss supplements and 17 per cent weight loss injections.

People living in Northern Ireland are the most likely to turn to the host of new weight loss injections (36 per cent) to lose weight.

“The statistics are a wake-up call,” said Melissa Snover, founder and CEO of Nourished.

“Poor diet and nutrition are not just about systemic issues like food accessibility and affordability, but personal choices and societal pressures to lose weight are leading individuals to the overuse and reliance on restrictive diets and weight loss products which are equally impacting the nutrition of the nation.

“We must address these challenges head-on to prevent a full-blown health crisis.”

In light of these alarming statistics, Snover believes the importance of proper nutrition and supplementation becomes evident. Vitamin supplements play a crucial role in combating malnutrition, especially for vulnerable populations.

Despite this, a quarter (25 per cent) of people admitted to never taking a vitamin supplement with over half (57 per cent) currently not taking any vitamin supplements at all.

“The pressure to conform to societal standards of beauty and fitness is driving people to unhealthy extremes,” said Snover.

“At Nourished, we believe in promoting balanced, sustainable health practices which are unique to the individual’s needs, over quick fixes. Yet usage of weight loss supplements and more recently injections are on the rise and even though it’s been proven that fad diets don’t work research has revealed that two thirds of Brits are consistently on a diet.

“A study in 2021 highlighted that rapid weight loss can lead to metabolic syndrome, including conditions such as high blood pressure, blood sugar and abnormal cholesterol levels. Not enough individuals are fully aware of the serious health consequences of prioritising weight loss over nutrition and more must be done to educate individuals of the risks.”

She added: “Adequate intake of vitamins such as A, C, and D is critical for maintaining a robust immune system, which is particularly important for children in their developmental years. Nutrients like iron, zinc, and omega-3 fatty acids are vital for brain development and cognitive function.

“Deficiencies in these nutrients can impair learning and concentration, and consistent nutritional deficiencies can lead to chronic health issues such as anaemia, stunted growth, and increased susceptibility to infections.”

In response to the rising trend of crash diets and weight loss supplements, Nourished has launched the Slimming Support Stack.

It is a specially curated formulation designed to tackle common deficiencies that arise during weight management journeys. Key ingredients include Ovoderm collagen for skin and joint health, CoQ10 for energy and cardiovascular support, and vitamin D for immune health.

The stack also contains vitamin B12 to aid energy and normal psychological function, and vitamin A for healthy vision, immune function, and hair, skin and nail support, addressing common deficiencies associated with typical weight management methods.

These nutrients are crucial for maintaining overall health and compensating for the potential lack of essential vitamins and minerals during dieting and weight loss efforts.

Nourished Slimming Support Stacks are available online from £28. For more information, visit www.get-nourished.com.

Diagnosis

WHO launches AI tool for reproductive health information

Published

on

The World Health Organization (WHO) has launched an AI tool in beta to help policymakers, experts and healthcare professionals access sexual and reproductive health information faster.

Called ChatHRP, the tool was created by WHO’s Human Reproduction Programme and draws only on verified research and guidance collected by HRP and WHO.

It uses natural language processing and retrieval-augmented generation to produce referenced content and cut the time spent searching through documents across different platforms and databases.

WHO said ChatHRP also has multilingual capabilities and low-bandwidth functionality to support use in a wide range of settings.

The beta-testing phase is aimed at a broad professional audience, including policymakers, healthcare workers, researchers and civil society groups.

WHO said the tool can help users quickly access up-to-date evidence, find sources for academic work and verify information on sexual and reproductive health and rights.

Examples of questions it can answer include the latest violence against women data in Oceania for women aged 15 to 49, recommendations on managing diabetes during pregnancy, and whether PrEP and contraception can be used at the same time. PrEP is medicine used to reduce the risk of getting HIV.

WHO added that the system will be updated regularly as new HRP materials are published and includes a feedback loop so users can flag gaps in the information provided.

The launch comes amid wider concern about misinformation in sexual and reproductive health.

A 2025 scoping review found that misinformation in digital spaces is a systemic issue that can undermine human rights, reinforce discriminatory social norms and exclude marginalised voices.

The review also said misinformation can affect health systems by shaping provider knowledge and practice, disrupting service delivery and creating barriers to equitable care.

WHO said ChatHRP is intended to give users streamlined access to reliable information as a counter to “algorithms, opinions, or misinformation”.

Continue Reading

Wellness

Women’s HealthX unveils Northwell Health, Corewell Health, Biogen & more to headline Chronic Disease stage

Published

on

Women’s HealthX has announced its lineup of healthcare trailblazers speaking on Chronic Disease Management, alongside other specialisations including Fertility, Sexual Health, Maternity, Menopause and Cognitive Health, taking a holistic approach to women’s health.

It will bring together 750+ leaders across pharma, health systems, and innovation to address one of the most urgent and underexamined challenges in healthcare; the sex difference gap in data and evidence.

Since cardiovascular disease remains the leading cause of death among women globally, and autoimmune and neurological conditions affect women at significantly higher rates, Women’s HealthX will home in on chronic disease management with 17+ sessions spotlighting case studies and lessons learned.

The Chronic Disease Management Stage at Women’s HealthX responds directly to this gap, convening senior decision makers and innovators to explore how sex specific science, digital health, and new care models can reshape outcomes for women.

Attending pharma & healthcare organisations include:

  • Tracy Sims, Executive Director, Cardiometabolic Health, Eli Lilly
  • Adrian Kielhorn, Senior Director, Global Head HEOR Neurology, Alexion Pharmaceuticals
  • Lauren Powell, Head of Health Equity and Clinical Innovation, Biogen
  • Amy Kao, SVP, Head of Neuroscience and Immunology Research, EMD Serono
  • Stella Vnook, Executive Chair and CEO, Kaida Biopharma
  • Amanda Borsky, Director, Clinical Research, Northwell Health
  • Lacey McIntosh, Division Chief, Oncologic and Molecular Imaging, UMass Memorial Medical Center
  • Nicole Turck, Vice President Operations, Women’s Health, Corewell Health
  • Mette Dyhrberg, CEO, Autoimmune Registry
  • Lyn Agostinelli, Principal Consultant, Halloran Consulting Group

Sessions addressing the real gaps in women’s chronic care

The agenda features a series of high impact sessions tackling the structural and scientific gaps in women’s health:

  • Improving outcomes in obesity through evidence based person centered care: Eli Lilly
  • Tackling sex based health inequities by breaking down barriers and bias: Alexion Pharmaceuticals
  • Close the health equity gap in women’s health by improving how autoimmune diseases are diagnosed, treated and managed: Autoimmune Registry
  • How a GYN only care model is driving faster access to gynecological care: Corewell Health
  • Transforming early detection in ovarian cancer: new pathways to accuracy, safety, and better outcomes: UMass Memorial Medical Center

Panel discussions include:

  • Why chronic disease looks different in women and why health systems haven’t adapted: Biogen, Kaida Biopharma, EMD Serono
  • How can we better engage with our customers: Northwell Health, Halloran Consulting Group

Health equity starts here. REGISTER YOUR PLACE

Why This Matters Now

Women’s HealthX positions chronic disease not just as a clinical challenge, but as a critical frontier for innovation, investment, and system redesign.

From AI powered monitoring and digital therapeutics to real world data and integrated care pathways, the stage highlights where meaningful progress is already being made and where the biggest opportunities lie.

For the FemTech ecosystem, this represents a pivotal moment: aligning technology, clinical insight, and commercial strategy to finally close the long standing data and care gaps in women’s health.

About Women’s HealthX

Women’s HealthX is where the transformation of women’s health begins at its true foundation: data, science, and evidence.

It’s the leading event dedicated to closing the sex difference data gap and accelerating breakthroughs through science driven, real world case studies.

Taking place on December 3 to 4, 2026 in Boston, USA, the exhibition will bring together more than 750 healthcare leaders, including clinicians, payers, employers, investors, and policymakers.

Seven different stages with 150+ expert speakers taking an holistic approach to women’s health. From fertility, maternity, sexual health, cognitive health, menopause and chronic disease, we address care at every stage of a woman’s life.

Continue Reading

Wellness

Elimination of cervical cancer in EU an ‘achievable goal’, report finds

Published

on

Cervical cancer elimination in the EU is becoming achievable as HPV vaccination coverage rises, a new report says.

As Europe marks European Immunisation Week 2026, the European Centre for Disease Prevention and Control said progress in human papillomavirus vaccination is continuing across the EU and European Economic Area.

All EU and European Economic Area countries now recommend HPV vaccination for adolescent girls and boys as part of their immunisation programmes, marking a major step forward in Europe’s cancer prevention efforts.

Bruno Ciancio, head of unit, directly transmitted diseases and vaccine preventable diseases at the European Centre for Disease Prevention and Control, said: “The elimination of cervical cancer in the EU/EEA is becoming an achievable goal, thanks to the HPV vaccination programmes.

“The progress we are seeing across Europe demonstrates what can be accomplished when countries invest consistently in effective immunisation strategies.

“We are closely monitoring this progress and actively supporting countries to accelerate uptake and move faster towards cervical cancer elimination.”

According to the report, three EU and European Economic Area countries, Iceland, Portugal and Norway, have reached the 2024 EU Council Recommendation target of 90 per cent HPV vaccination coverage among girls by the age of 15.

Fifteen years after HPV vaccination programmes were introduced in Europe, a growing body of evidence confirms the vaccine is highly effective in preventing cervical cancer.

Large-scale studies from Sweden, the Netherlands and Denmark, as well as other parts of the world, have shown significant reductions in HPV infections and precancerous lesions, which are abnormal cell changes that can develop into cancer if left untreated, alongside falling cervical cancer rates among vaccinated women.

Since 2020, European countries have reported a decreased incidence of cervical cancer among vaccinated women.

Studies from Sweden, Denmark and the UK show that early administration of the vaccine increases its full protective potential.

A Swedish study suggested that vaccinating girls before their 17th birthday reduced the incidence of cervical cancer by 88 per cent.

An additional six-year follow-up found a sustained reduction in cervical cancer risk and a population-level decline in invasive cervical cancer incidence after HPV vaccination.

The report showed that vaccination programmes and health system design are critical factors in reaching high levels of HPV vaccination coverage.

Evidence from across Europe showed that school-based vaccination programmes are particularly effective and tend to reach higher levels of coverage among both girls and boys.

Continue Reading

Trending

Copyright © 2025 Aspect Health Media Ltd. All Rights Reserved.